Pandemic influenza vaccine
Phase 1Vaccine
Sinovac Biotech Co., LtdPandemic influenza vaccine is one of 22 vaccine programs targeting Influenza. It is currently in Phase 1.
1
Indications
8
Total Trials
0
Active Trials
21
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
1053 competitors in Influenza
#DrugCompanyPhaseTrials
1Fluzone
SanofiPreclinical
Fluzone
GSKPreclinical
Avigan
AAppili Therapeutics Inc.
Preclinical
Quadrivalent Influenza Vaccine
SanofiPreclinical
COMIRNATY
PfizerPreclinical
Antihistamine
Arrowhead PharmaceuticalsPreclinical
Pandemic influenza vaccine
Sinovac Biotech Co., LtdPhase 1
Influenza A/H5N1
NNational Institute of Allergy and Infectious Diseases (NIAID)
Preclinical
PD-1/PD-L1 Inhibitors
CChuangzhen Chen
Preclinical
Fluvirin
NovartisPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Influenza8 trials
Show 5 more trials
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Pandemic influenza vaccine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Vaccine[2]
- Highest Phase
- Phase 1[1]
- Company